Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers.

Zhong, Li-Xia; Wu, Mo-Li; Li, Hong; Liu, Jia; Lin, Li-Zhu

Zhong, Li-Xia; Wu, Mo-Li; Li, Hong; Liu, Jia; Lin, Li-Zhu.

Afiliação

Zhong LX; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510407, Guangdong, People's Republic of China.
Wu ML; Liaoning Laboratory of Cancer Genetics and Epigenetics, Department of Cell Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, People's Republic of China.
Li H; Liaoning Laboratory of Cancer Genetics and Epigenetics, Department of Cell Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, People's Republic of China.
Liu J; Liaoning Laboratory of Cancer Genetics and Epigenetics, Department of Cell Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, People's Republic of China.
Lin LZ; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510407, Guangdong, People's Republic of China.

Cancer Manag Res ; 11: 6113-6124, 2019.

Article em En | MEDLINE | ID: mdl-31456648

Palavras-chave

apoptosis; intraperitoneal administration; rat orthotopic ovarian cancer; resveratrol

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Cancer Manag Res Ano de publicação: 2019 Tipo de documento: Article